NCT02445573

Brief Summary

The purpose of this study is to preliminarily assess the efficacy of electroacupuncture (EA) for women with pure stress urinary incontinence (SUI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 15, 2015

Completed
1 month until next milestone

Results Posted

Study results publicly available

June 15, 2015

Completed
Last Updated

June 15, 2015

Status Verified

May 1, 2015

Enrollment Period

1.6 years

First QC Date

May 13, 2015

Results QC Date

May 15, 2015

Last Update Submit

May 29, 2015

Conditions

Keywords

stress urinary incontinenceelectroacupunctureefficacy

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline of Urine Leakage Measured by 1-hour Pad Test

    Baseline and week 6

Secondary Outcomes (3)

  • Change From Baseline of the 72-hour Incontinence Episode Frequency (IEF)

    Baseline, weeks 1-6, weeks 15-18 and weeks 27-30

  • Change From Baseline of the Total ICIQ-SF Scores

    Baseline, and weeks 6, 18 and 30

  • Patient Self-evaluation of Therapeutic Effect

    weeks 6, 18 and 30

Other Outcomes (1)

  • Adverse Events

    weeks 1-30

Study Arms (2)

EA group

ACTIVE COMPARATOR
Other: EA

Sham EA group

PLACEBO COMPARATOR
Other: sham EA

Interventions

EAOTHER

When acupuncturing, adhesive pads were first pasted on acupoints after sterilization in either group. In EA group, participants were needled at bilateral BL33 at an angle of 30 to 45 degree inward and downward, and at bilateral BL35 slightly toward upside and outside, to a depth of 50 to 60 mm using acupuncture needles of size 0.30×75 mm. Needles were then lifted, thrusted and twirled evenly for 3 times. Paired electrodes of EA apparatus were attached transversely to bilateral BL33 and BL35 (using real electrodes) respectively, with a continuous wave of 50 Hz and a current intensity of 1-5 milliampere (mA) for 30 min. Participants were treated with EA 3 sessions a week on alternate days for 6 successive weeks.

EA group
sham EAOTHER

When acupuncturing, adhesive pads were first pasted on acupoints after sterilization in either group. In sham EA group, participants were needled at sham BL33 and sham BL35, which were about 20 mm lateral to BL33 and BL35, respectively, with blunt needle tips piercing adhesive pads and not piercing the surface of the skin, using placebo needles of size 0.30×25 mm. Needles were then lifted, thrusted and twirled evenly for 3 times. Paired electrodes of EA apparatus were attached transversely to bilateral sham BL33 and sham BL35 (using sham electrodes) respectively. The parameters of sham EA apparatus and the treatment course were the same as in the EA group.

Sham EA group

Eligibility Criteria

Age40 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible women were 40 to 75 years of age, and met the clinical diagnosis recommendations of SUI by the International Consultation on Urological Diseases:
  • involuntary urine leakage on effort, exertion, sneezing or coughing which stopped when the stress ends;
  • visible involuntary leakage from the urethra synchronous with increased abdominal pressure, or a pad weight gain \>1 g in 1-hour pad test;
  • without symptoms of urinary frequency and urgency.

You may not qualify if:

  • Women were excluded from the study if they met any of the following criteria: \*other type of urinary incontinence (UI) (urge, mixed, or overflow UI, etc);
  • symptomatic urinary tract infection;
  • ever received UI or pelvic surgery;
  • a severity of pelvic organ prolapse ≥ degree 2;
  • residual urinary volume \>30 ml;
  • maximum flow rate ≤ 20 ml/s;
  • limited in walking, stairs climbing and running;
  • receiving specialized treatment for SUI, or taking medicine affecting bladder function;
  • serious cardiovascular, cerebral, liver, kidney, or psychiatric disease, diabetes, multiple system atrophy, injury of cauda equina, or myeleterosis;
  • being pregnant or breastfeeding;
  • with cardiac pacemaker, metal allergy or severe needle phobia;
  • unlike to give written formed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guang'anmen hospital of China Academy of Chinese Medical Sciences

Beijing, Beijing Municipality, 100053, China

Location

Related Publications (1)

  • Xu H, Liu B, Wu J, Du R, Liu X, Yu J, Liu Z. A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women with Pure Stress Urinary Incontinence. PLoS One. 2016 Mar 9;11(3):e0150821. doi: 10.1371/journal.pone.0150821. eCollection 2016.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Huanfang Xu
Organization
Guang'anmen hospital of China Academy of Chinese Medical Sciences

Study Officials

  • Zhishun Liu, doctor

    Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

May 13, 2015

First Posted

May 15, 2015

Study Start

December 1, 2012

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

June 15, 2015

Results First Posted

June 15, 2015

Record last verified: 2015-05

Locations